How to treat chronic idiopathic urticaria using ligerizumab

摘要

The present disclosure relates to a method of treating chronic idiopathic urticaria using an IgE antagonist, such as ligerizumab. An IgE antagonist, such as ligerizumab for treating a chronic idiopathic urticaria, for example, a drug for use in the disclosed use and method, medication regimen, pharmaceutical formulation, dosage form and kit are also disclosed herein.